CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Novo does another small deal, this time with drug delivery biotech Nanexa

PartnershipNeutral
AI Analysis

Summary

Swedish biotech Nanexa has licensed its long-acting drug delivery technology to Novo in a small development partnership.

Importance:3/10
Sentiment:
0.00
partnershiplicensingdrug_deliverysmall_deal
Related Companies

Read the original article

Published by Endpoints News on September 25, 2026 10:29 AM

Read Original